PsAID12 provisionally endorsed at OMERACT2018 as core outcome measure to assess Psoriatic Arthritis-specific Health-Related Quality of Life in clinical trials

OBJECTIVE: The GRAPPA-OMERACT psoriatic arthritis (PsA) working group is developing a Core Outcome Measurement Set for PsA clinical trials (randomized controlled trials and longitudinal observational studies) using the OMERACT Filter 2.1 instrument selection algorithm. Our objective was to assess th...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Rheumatol
Main Authors: Orbai, A-M, Holland, R, Leung, YY, Tillett, W, Goel, Niti, Christensen, Robin, McHugh, N, Gossec, L, de Wit, M, Højgaard, P, Coates, Laura, Mease, PJ, Birt, Julie, Fallon, Lara, FitzGerald, O, Ogdie, A, Shea, Beverley, Strand, V, Duffin, K Callis, Tugwell, P, Beaton, D, Gladman, DD
Formato: Artigo
Idioma:Inglês
Publicado em: 2018
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6571063/
https://ncbi.nlm.nih.gov/pubmed/30554154
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3899/jrheum.181077
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados